How effective is FITNET-NHS for children and young adults with CFS/ME?

Conditions

Paediatric CFS/ME Nervous System Diseases Postviral fatigue syndrome

Esther Crawley, Emma Anderson, Madeleine Cochrane, Beverly A. Shirkey, Roxanne Parslow et al. (22 authors)

Health Technology Assessment2024-10-013 citations

Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial

Emma Anderson, Roxanne Parslow, William Hollingworth, Nicola Mills, Lucy Beasant et al. (18 authors)

Journal of Medical Internet Research2020-08-1217 citations

10.2196/17768

Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.

Baos S, Brigden A, Anderson E, Hollingworth W, Price S, Mills N, Beasant L, Gaunt D, Garfield K, Metcalfe C, Parslow R, Downing H, Kessler D, Macleod J, Stallard P, Knoop H, Van de Putte E, Nijhof S, Bleijenberg G, Crawley E.

2018-02-2217 citations

10.1186/s13063-018-2500-3

Interventions

Current interventions as of 09/07/2018: A single-centre randomised controlled trial investigating the effectiveness and cost-effectiveness of using FITNET-NHS (internet delivered cognitive behavioural

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Children aged 11 to 17 years 2. Children with CFS/ME (defined using NICE guidance) 3. Children with no local specialist CFS/ME service

Exclusion criteria

Exclusion criteria: 1. Children not disabled by fatigue 2. Children whose fatigue is due to another cause 3. Children or parents unable to complete video calls (e.g. Skype) or FITNET-NHS modules (e.g. unable to read FITNET-NHS material, or significant development problems, or limited internet access, unwilling/unable to set up personal email address/video call (e.g. Skype) account)

Design outcomes

Primary

Measure	Time frame
Disability measured using the Physical Function Scale (SF-36-PFS) at 6 months after randomisation	—

Secondary

Measure	Time frame
Secondary outcomes are measured at 3, 6 and 12 months unless otherwise specified, and include: 1. SF36-PFS measured at 3 and 12 months after randomisation 2. Fatigue (Chalder scale and Checklist Individual Strength (CIS) fatigue severity subscale) 3. School attendance (self-report school or home tuition) 4. Mood (Revised Children’s Anxiety and Depression Scale (RCADS)) 5. Pain visual analogue scale 6. Clinical Global Impression Scale 7. Quality of Life (EQ-5D-Y) 8. Parental completed: Healthcare Resource Use questionnaire 9. Parental completed: Work Productivity & Activity Impairment Questionnaire General Health (WPAI:GH)	—

Measure

Time frame

Secondary outcomes are measured at 3, 6 and 12 months unless otherwise specified, and include: 1. SF36-PFS measured at 3 and 12 months after randomisation 2. Fatigue (Chalder scale and Checklist Individual Strength (CIS) fatigue severity subscale) 3. School attendance (self-report school or home tuition) 4. Mood (Revised Children’s Anxiety and Depression Scale (RCADS)) 5. Pain visual analogue scale 6. Clinical Global Impression Scale 7. Quality of Life (EQ-5D-Y) 8. Parental completed: Healthcare Resource Use questionnaire 9. Parental completed: Work Productivity & Activity Impairment Questionnaire General Health (WPAI:GH)

—

Countries

England, United Kingdom

Outcome results

None listed